$39 Million is the total value of Copernicus Capital Management, LLC's 14 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 69.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $5,198,000 | +22.2% | 18,990 | -0.1% | 13.33% | +66.5% |
| ZTS | Buy | ZOETIS INCcl a | $5,075,000 | +30.6% | 50,413 | +10.9% | 13.01% | +77.8% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $4,055,000 | – | 85,000 | +100.0% | 10.40% | – |
| HRTX | Buy | HERON THERAPEUTICS INC | $3,323,000 | +37.8% | 135,946 | +46.2% | 8.52% | +87.6% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $3,286,000 | -39.7% | 17,863 | -45.7% | 8.43% | -17.9% |
| UNH | New | UNITEDHEALTH GROUP INC | $2,967,000 | – | 12,000 | +100.0% | 7.61% | – |
| SYK | Sell | STRYKER CORP | $2,885,000 | -25.3% | 14,608 | -40.7% | 7.40% | +1.8% |
| IQV | New | IQVIA HLDGS INC | $2,877,000 | – | 20,000 | +100.0% | 7.38% | – |
| GILD | Sell | GILEAD SCIENCES INC | $2,662,000 | -57.0% | 40,946 | -58.6% | 6.83% | -41.4% |
| CDNA | Buy | CAREDX INC | $2,047,000 | +48.1% | 64,944 | +18.1% | 5.25% | +101.7% |
| HZNP | New | HORIZON PHARMA PLC | $1,744,000 | – | 66,000 | +100.0% | 4.47% | – |
| ILMN | Sell | ILLUMINA INC | $1,653,000 | -73.5% | 5,320 | -74.5% | 4.24% | -64.0% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $914,000 | -83.6% | 1,602 | -86.2% | 2.34% | -77.6% |
| NVRO | New | NEVRO CORP | $313,000 | – | 5,000 | +100.0% | 0.80% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -15,000 | -100.0% | -3.78% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -11,500 | -100.0% | -5.11% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -59,956 | -100.0% | -7.40% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -68,461 | -100.0% | -9.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.